Pericytes in chronic lung disease

International Archives of Allergy and Immunology

Volumn 164, Issue 3, 2014, Pages 178-188

  Rowley, Jessica E ^a   Johnson, Jill R ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

Allergic asthma; Chronic obstructive pulmonary disorder; Fibrosis; Inflammation; Lung; Stem cells

Indexed keywords

5' NUCLEOTIDASE; ALKALINE PHOSPHATASE; ALPHA SMOOTH MUSCLE ACTIN; ANGIOPOIETIN RECEPTOR; CD146 ANTIGEN; COLLAGEN; COLLAGEN TYPE 4; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; ENDOGLIN; HERMES ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; MICROSOMAL AMINOPEPTIDASE; NEURAL GLIAL ANTIGEN 2; PLATELET DERIVED GROWTH FACTOR BB; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; THY 1 ANTIGEN; UNCLASSIFIED DRUG;

ADIPOCYTE; ALLERGIC ASTHMA; CARTILAGE CELL; CELL ACTIVATION; CELL MIGRATION; CELL TYPE; CHRONIC LUNG DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; FORCED EXPIRATORY VOLUME; HUMAN; INFLAMMATION; INFLAMMATORY DISEASE; KIDNEY FIBROSIS; LIVER FIBROSIS; LUNG BLOOD VESSEL; LUNG FIBROSIS; MESENCHYMAL STEM CELL; MYCOPLASMA PULMONIS; MYOFIBROBLAST; NONHUMAN; OSTEOCYTE; PERICYTE; PULMONARY HYPERTENSION; REVIEW; ASTHMA; CELL DIFFERENTIATION; IMMUNOLOGY; LUNG; MESENCHYMAL STROMA CELL; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY;

ASTHMA; CELL DIFFERENTIATION; HUMANS; HYPERTENSION, PULMONARY; INFLAMMATION; LUNG; MESENCHYMAL STROMAL CELLS; MYOFIBROBLASTS; NEOVASCULARIZATION, PATHOLOGIC; PERICYTES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY FIBROSIS;

EID: 84904272119     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000365051     Document Type: Review

References (90)

1. Armulik A, Abramsson A, Betsholtz C: Endothelial/ pericyte interactions. Circ Res 2005; 97: 512-523.
2. Diaz-Flores L, Gutierrez R, Madrid JF, Varela H, Valladares F, Acosta E, Martin-Vasallo P, Diaz-Flores L Jr: Pericytes. Morphofunction, interactions and pathology in a quiescent and activated mesenchymal cell niche. Histol Histopathol 2009; 24: 909-969.
3. Feng J, Mantesso A, Sharpe PT: Perivascular cells as mesenchymal stem cells. Expert Opin Biol Ther 2010; 10: 1441-1451.
4. Hall CN, Reynell C, Gesslein B, Hamilton NB, Mishra A, Sutherland BA, OFarrell FM, Buchan AM, Lauritzen M, Attwell D: Capillary pericytes regulate cerebral blood flow in health and disease. Nature 2014; 508: 55-60.
5. Diaz-Flores L, Gutierrez R, Garcia MP, Diaz-Flores L Jr, Valladares F, Madrid JF: Ultrastructure of myopericytoma: a continuum of transitional phenotypes of myopericytes. Ultrastruct Pathol 2012; 36: 189-194.
6. Gaengel K, Genove G, Armulik A, Betsholtz C: Endothelial-mural cell signaling in vascular development and angiogenesis. Arterioscler Thromb Vasc Biol 2009; 29: 630-638.
7. Armulik A, Genove G, Betsholtz C: Pericytes: developmental, physiological, and pathological perspectives, problems, and promises. Dev Cell 2011; 21: 193-215.
8. Bergers G, Song S: The role of pericytes in blood-vessel formation and maintenance. Neuro Oncol 2005; 7: 452-464.
9. Nehls V, Drenckhahn D: Heterogeneity of microvascular pericytes for smooth muscle type alpha-actin. J Cell Biol 1991; 113: 147-154.
10. Corselli M, Crisan M, Murray IR, West CC, Scholes J, Codrea F, Khan N, Peault B: Identification of perivascular mesenchymal stromal/ stem cells by flow cytometry. Cytometry A 2013; 83: 714-720.
11. Crisan M, Yap S, Casteilla L, Chen CW, Corselli M, Park TS, Andriolo G, Sun B, Zheng B, Zhang L, et al: A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 2008; 3: 301-313.
12. Nees S, Weiss DR, Senftl A, Knott M, Forch S, Schnurr M, Weyrich P, Juchem G: Isolation, bulk cultivation, and characterization of coronary microvascular pericytes: the second most frequent myocardial cell type in vitro. Am J Physiol Heart Circ Physiol 2012; 302:H69-H84.
13. Neng L, Zhang F, Kachelmeier A, Shi X: Endothelial cell, pericyte, and perivascular resident macrophage-type melanocyte interactions regulate cochlear intrastrial fluid-blood barrier permeability. J Assoc Res Otolaryngol 2013; 14: 175-185.
14. Tigges U, Welser-Alves JV, Boroujerdi A, Milner R: A novel and simple method for culturing pericytes from mouse brain. Microvasc Res 2012; 84: 74-80.
15. Lin SL, Kisseleva T, Brenner DA, Duffield JS: Pericytes and perivascular fibroblasts are the primary source of collagen-producing cells in obstructive fibrosis of the kidney. Am J Pathol 2008; 173: 1617-1627.
16. Birbrair A, Zhang T, Wang ZM, Messi ML, Enikolopov GN, Mintz A, Delbono O: Skeletal muscle pericyte subtypes differ in their differentiation potential. Stem Cell Res 2013; 10: 67-84.
17. Mederacke I, Hsu CC, Troeger JS, Huebener P, Mu X, Dapito DH, Pradere JP, Schwabe RF: Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology. Nat Commun 2013; 4: 2823.
18. Hung C, Linn G, Chow YH, Kobayashi A, Mittelsteadt K, Altemeier WA, Gharib SA, Schnapp LM, Duffield JS: Role of lung pericytes and resident fibroblasts in the pathogenesis of pulmonary fibrosis. Am J Respir Crit Care Med 2013; 188: 820-830.
19. Ricard N, Tu L, Le Hiress M, Huertas A, Phan C, Thuillet R, Sattler C, Seferian A, Fadel E, Montani D, et al: Increased pericyte coverage mediated by endothelial derived fibroblast growth factor-2 and interleukin-6 is a source of smooth muscle-like cells in pulmonary hypertension. Circulation 2014; 129: 1586-1597.
20. Rock JR, Barkauskas CE, Cronce MJ, Xue Y, Harris JR, Liang J, Noble PW, Hogan BL: Multiple stromal populations contribute to pulmonary fibrosis without evidence for epithelial to mesenchymal transition. Proc Natl Acad Sci USA 2011; 108:E1475-E1483.
21. Zehendner CM, Wedler HE, Luhmann HJ: A novel in vitro model to study pericytes in the neurovascular unit of the developing cortex. PLoS One 2013; 8:e81637.
22. Friedenstein AJ, Piatetzky-Shapiro II, Petrakova KV: Osteogenesis in transplants of bone marrow cells. J Embryol Exp Morphol 1966; 16: 381-390.
23. da Silva Meirelles L, Chagastelles PC, Nardi NB: Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci 2006; 119: 2204-2213.
24. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop D, Horwitz E: Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006; 8: 315-317.
25. Farrington-Rock C, Crofts NJ, Doherty MJ, Ashton BA, Griffin-Jones C, Canfield AE: Chondrogenic and adipogenic potential of microvascular pericytes. Circulation 2004; 110: 2226-2232.
26. Spitzer TL, Rojas A, Zelenko Z, Aghajanova L, Erikson DW, Barragan F, Meyer M, Tamaresis JS, Hamilton AE, Irwin JC, Giudice LC: Perivascular human endometrial mesenchymal stem cells express pathways relevant to self-renewal, lineage specification, and functional phenotype. Biol Reprod 2012; 86: 58.
27. Li H, Usas A, Poddar M, Chen CW, Thompson S, Ahani B, Cummins J, Lavasani M, Huard J: Platelet-rich plasma promotes the proliferation of human muscle derived progenitor cells and maintains their stemness. PLoS One 2013; 8:e64923.
28. Foronjy RF, Majka SM: The potential for resident lung mesenchymal stem cells to promote functional tissue regeneration: understanding microenvironmental cues. Cells 2012; 1: 874.
29. McQualter JL, Brouard N, Williams B, Baird BN, Sims-Lucas S, Yuen K, Nilsson SK, Simmons PJ, Bertoncello I: Endogenous fibroblastic progenitor cells in the adult mouse lung are highly enriched in the Sca-1 positive cell fraction. Stem Cells 2009; 27: 623-633.
30. Jun D, Garat C, West J, Thorn N, Chow K, Cleaver T, Sullivan T, Torchia EC, Childs C, Shade T, et al: The pathology of bleomycininduced fibrosis is associated with loss of resident lung mesenchymal stem cells that regulate effector T-cell proliferation. Stem Cells 2011; 29: 725-735.
31. Summer R, Fitzsimmons K, Dwyer D, Murphy J, Fine A: Isolation of an adult mouse lung mesenchymal progenitor cell population. Am J Respir Cell Mol Biol 2007; 37: 152-159.
32. Martin J, Helm K, Ruegg P, Varella-Garcia M, Burnham E, Majka S: Adult lung side population cells have mesenchymal stem cell potential. Cytotherapy 2008; 10: 140-151.
33. Weibel ER: On pericytes, particularly their existence on lung capillaries. Microvasc Res 1974; 8: 218-235.
34. Postma DS, Reddel HK, ten Hacken NH, van den Berge M: Asthma and chronic obstructive pulmonary disease: similarities and differences. Clin Chest Med 2014; 35: 143-156.
35. Bringardner BD, Baran CP, Eubank TD, Marsh CB: The role of inflammation in the pathogenesis of idiopathic pulmonary fibrosis. Antioxid Redox Signal 2008; 10: 287-301.
36. Nourshargh S, Hordijk PL, Sixt M: Breaching multiple barriers: leukocyte motility through venular walls and the interstitium. Nat Rev Mol Cell Biol 2010; 11: 366-378.
37. Wang S, Voisin MB, Larbi KY, Dangerfield J, Scheiermann C, Tran M, Maxwell PH, Sorokin L, Nourshargh S: Venular basement membranes contain specific matrix protein low expression regions that act as exit points for emigrating neutrophils. J Exp Med 2006; 203: 1519-1532.
38. Voisin MB, Woodfin A, Nourshargh S: Monocytes and neutrophils exhibit both distinct and common mechanisms in penetrating the vascular basement membrane in vivo. Arterioscler Thromb Vasc Biol 2009; 29: 1193-1199.
39. Ayres-Sander CE, Lauridsen H, Maier CL, Sava P, Pober JS, Gonzalez AL: Transendothelial migration enables subsequent transmigration of neutrophils through underlying pericytes. PLoS One 2013; 8:e60025.
40. Lauridsen HM, Pober JS, Gonzalez AL: A composite model of the human postcapillary venule for investigation of microvascular leukocyte recruitment. FASEB J 2014; 28: 1166-1180.
41. Stark K, Eckart A, Haidari S, Tirniceriu A, Lorenz M, von Bruhl ML, Gartner F, Khandoga AG, Legate KR, Pless R, et al: Capillary and arteriolar pericytes attract innate leukocytes exiting through venules and instruct them with pattern-recognition and motility programs. Nat Immunol 2013; 14: 41-51.
42. Proebstl D, Voisin MB, Woodfin A, Whiteford J, DAcquisto F, Jones GE, Rowe D, Nourshargh S: Pericytes support neutrophil subendothelial cell crawling and breaching of venular walls in vivo. J Exp Med 2012; 209: 1219-1234.
43. Wang S, Cao C, Chen Z, Bankaitis V, Tzima E, Sheibani N, Burridge K: Pericytes regulate vascular basement membrane remodeling and govern neutrophil extravasation during inflammation. PLoS One 2012; 7:e45499.
44. Hurtado-Alvarado G, Cabanas-Morales AM, Gomez-Gonzalez B: Pericytes: brain-immune interface modulators. Front Integr Neurosci 2014; 7: 80.
45. Pieper C, Marek JJ, Unterberg M, Schwerdtle T, Galla HJ: Brain capillary pericytes contribute to the immune defense in response to cytokines or LPS in vitro. Brain Res 2014; 1550: 1-8.
46. Tigges U, Boroujerdi A, Welser-Alves JV, Milner R: TNF-α promotes cerebral pericyte remodeling in vitro, via a switch from α1 to α2 integrins. J Neuroinflammation 2013; 10: 33.
47. Fuxe J, Tabruyn S, Colton K, Zaid H, Adams A, Baluk P, Lashnits E, Morisada T, Le T, OBrien S, et al: Pericyte requirement for antileak action of angiopoietin-1 and vascular remodeling in sustained inflammation. Am J Pathol 2011; 178: 2897-2909.
48. Greenhalgh SN, Iredale JP, Henderson NC: Origins of fibrosis: pericytes take centre stage. F1000Prime Rep 2013; 5: 37.
49. Wynn TA: Cellular and molecular mechanisms of fibrosis. J Pathol 2008; 214: 199-210.
50. Rosenbloom J, Castro SV, Jimenez SA: Narrative review: fibrotic diseases -cellular and molecular mechanisms and novel therapies. Ann Intern Med 2010; 152: 159-166.
51. Steele MP, Schwartz DA: Molecular mechanisms in progressive idiopathic pulmonary fibrosis. Annu Rev Med 2013; 64: 265-276.
52. Moore BB, Lawson WE, Oury TD, Sisson TH, Raghavendran K, Hogaboam CM: Animal models of fibrotic lung disease. Am J Respir Cell Mol Biol 2013; 49: 167-179.
53. Wynn TA: Integrating mechanisms of pulmonary fibrosis. J Exp Med 2011; 208: 1339-1350.
54. Greenhalgh SN, Conroy KP, Henderson NC: Healing scars: targeting pericytes to treat fibrosis. QJM 2014, Epub ahead of print.
55. Dulauroy S, Di Carlo SE, Langa F, Eberl G, Peduto L: Lineage tracing and genetic ablation of ADAM12 + perivascular cells identify a major source of profibrotic cells during acute tissue injury. Nat Med 2012; 18: 1262-1270.
56. Humphreys BD, Lin SL, Kobayashi A, Hudson TE, Nowlin BT, Bonventre JV, Valerius MT, McMahon AP, Duffield JS: Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis. Am J Pathol 2010; 176: 85-97.
57. Kisseleva T, Cong M, Paik Y, Scholten D, Jiang C, Benner C, Iwaisako K, Moore-Morris T, Scott B, Tsukamoto H, et al: Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis. Proc Natl Acad Sci USA 2012; 109: 9448-9453.
58. Karvonen HM, Lehtonen ST, Harju T, Sormunen RT, Lappi-Blanco E, Makinen JM, Laitakari K, Johnson S, Kaarteenaho RL: Myofibroblast expression in airways and alveoli is affected by smoking and COPD. Respir Res 2013; 14: 84.
59. Togo S, Holz O, Liu X, Sugiura H, Kamio K, Wang X, Kawasaki S, Ahn Y, Fredriksson K, Skold CM, et al: Lung fibroblast repair functions in patients with chronic obstructive pulmonary disease are altered by multiple mechanisms. Am J Respir Crit Care Med 2008; 178: 248-260.
60. Hashimoto M, Tanaka H, Abe S: Quantitative analysis of bronchial wall vascularity in the medium and small airways of patients with asthma and COPD. Chest 2005; 127: 965-972.
61. Calabrese C, Bocchino V, Vatrella A, Marzo C, Guarino C, Mascitti S, Tranfa CM, Cazzola M, Micheli P, Caputi M, Marsico SA: Evidence of angiogenesis in bronchial biopsies of smokers with and without airway obstruction. Respir Med 2006; 100: 1415-1422.
62. Konigshoff M, Kneidinger N, Eickelberg O: TGF-beta signaling in COPD: deciphering genetic and cellular susceptibilities for future therapeutic regimen. Swiss Med Wkly 2009; 139: 554-563.
63. Barnes PJ: Mediators of chronic obstructive pulmonary disease. Pharmacol Rev 2004; 56: 515-548.
64. Sieczkiewicz GJ, Herman IM: TGF-β 1 signaling controls retinal pericyte contractile protein expression. Microvasc Res 2003; 66: 190-196.
65. Mendes ES, Campos MA, Wanner A: Airway blood flow reactivity in healthy smokers and in ex-smokers with or without COPD. Chest 2006; 129: 893-898.
66. Kranenburg AR, de Boer WI, Alagappan VK, Sterk PJ, Sharma HS: Enhanced bronchial expression of vascular endothelial growth factor and receptors (Flk-1 and Flt-1) in patients with chronic obstructive pulmonary disease. Thorax 2005; 60: 106-113.
67. Kanazawa H, Asai K, Hirata K, Yoshikawa J: Possible effects of vascular endothelial growth factor in the pathogenesis of chronic obstructive pulmonary disease. Am J Med 2003; 114: 354-358.
68. Kasahara Y, Tuder RM, Taraseviciene-Stewart L, Le Cras TD, Abman S, Hirth PK, Waltenberger J, Voelkel NF: Inhibition of VEGF receptors causes lung cell apoptosis and emphysema. J Clin Invest 2000; 106: 1311-1319.
69. Darland DC, Massingham LJ, Smith SR, Piek E, Saint-Geniez M, DAmore PA: Pericyte production of cell-associated VEGF is differentiation-dependent and is associated with endothelial survival. Dev Biol 2003; 264: 275-288.
70. Cho YJ, Ma JE, Yun EY, Kim YE, Kim HC, Lee JD, Hwang YS, Jeong YY: Serum angiopoietin-2 levels are elevated during acute exacerbations of COPD. Respirology 2011; 16: 284-290.
71. Kratzer A, Chu HW, Salys J, Moumen Z, Leberl M, Bowler R, Cool C, Zamora M, Taraseviciene-Stewart L: Endothelial cell adhesion molecule CD146: implications for its role in the pathogenesis of COPD. J Pathol 2013; 230: 388-398.
72. Al-Muhsen S, Johnson JR, Hamid Q: Remodeling in asthma. J Allergy Clin Immunol 2011; 128: 451-462, quiz 463-464.
73. Bousquet J, Vignola AM, Chanez P, Campbell AM, Bonsignore G, Michel FB: Airways remodelling in asthma: no doubt, no more? Int Arch Allergy Immunol 1995; 107: 211-214.
74. Wilson JW, Hii S: The importance of the airway microvasculature in asthma. Curr Opin Allergy Clin Immunol 2006; 6: 51-55.
75. Zanini A, Chetta A, Imperatori AS, Spanevello A, Olivieri D: The role of the bronchial microvasculature in the airway remodelling in asthma and COPD. Respir Res 2010; 11: 132.
76. McDonald DM: The ultrastructure and permeability of tracheobronchial blood vessels in health and disease. Eur Respir J Suppl 1990; 12: 572s-585s.
77. Rydell-Tormanen K, Uller L, Erjefalt JS: Allergic airway inflammation initiates longterm vascular remodeling of the pulmonary circulation. Int Arch Allergy Immunol 2009; 149: 251-258.
78. Rydell-Tormanen K, Johnson JR, Fattouh R, Jordana M, Erjefalt JS: Induction of vascular remodeling in the lung by chronic house dust mite exposure. Am J Respir Cell Mol Biol 2008; 39: 61-67.
79. Lee CG, Ma B, Takyar S, Ahangari F, Delacruz C, He CH, Elias JA: Studies of vascular endothelial growth factor in asthma and chronic obstructive pulmonary disease. Proc Am Thorac Soc 2011; 8: 512-515.
80. Makinde TO, Agrawal DK: Increased expression of angiopoietins and Tie2 in the lungs of chronic asthmatic mice. Am J Respir Cell Mol Biol 2011; 44: 384-393.
81. Simoes DC, Vassilakopoulos T, Toumpanakis D, Petrochilou K, Roussos C, Papapetropoulos A: Angiopoietin-1 protects against airway inflammation and hyperreactivity in asthma. Am J Respir Crit Care Med 2008; 177: 1314-1321.
82. Hirota JA, Ask K, Farkas L, Smith JA, Ellis R, Rodriguez-Lecompte JC, Kolb M, Inman MD: In vivo role of platelet-derived growth factor-BB in airway smooth muscle proliferation in mouse lung. Am J Respir Cell Mol Biol 2011; 45: 566-572.
83. Hosaka K, Yang Y, Seki T, Nakamura M, Andersson P, Rouhi P, Yang X, Jensen L, Lim S, Feng N, et al: Tumour PDGF-BB expression levels determine dual effects of anti-PDGF drugs on vascular remodelling and metastasis. Nat Commun 2013; 4: 2129.
84. Lee-Fowler TM, Guntur V, Dodam J, Cohn LA, DeClue AE, Reinero CR: The tyrosine kinase inhibitor masitinib blunts airway inflammation and improves associated lung mechanics in a feline model of chronic allergic asthma. Int Arch Allergy Immunol 2012; 158: 369-374.
85. Rhee CK, Kim JW, Park CK, Kim JS, Kang JY, Kim SJ, Kim SC, Kwon SS, Kim YK, Park SH, Lee SY: Effect of imatinib on airway smooth muscle thickening in a murine model of chronic asthma. Int Arch Allergy Immunol 2011; 155: 243-251.
86. Yeager ME, Frid MG, Stenmark KR: Progenitor cells in pulmonary vascular remodeling. Pulm Circ 2011; 1: 3-16.
87. Patel MS, Taylor GP, Bharya S, Al-Sannaa N, Adatia I, Chitayat D, Suzanne Lewis ME, Human DG: Abnormal pericyte recruitment as a cause for pulmonary hypertension in Adams-Oliver syndrome. Am J Med Genet A 2004; 129A:294-299.
88. Assaad AM, Kawut SM, Arcasoy SM, Rosenzweig EB, Wilt JS, Sonett JR, Borczuk AC: Platelet-derived growth factor is increased in pulmonary capillary hemangiomatosis. Chest 2007; 131: 850-855.
89. Jones R, Capen D, Jacobson M: PDGF and microvessel wall remodeling in adult lung: imaging PDGF-Rβ and PDGF-BB molecules in progenitor smooth muscle cells developing in pulmonary hypertension. Ultrastruct Pathol 2006; 30: 267-281.
90. Pietras K, Pahler J, Bergers G, Hanahan D: Functions of paracrine PDGF signaling in the proangiogenic tumor stroma revealed by pharmacological targeting. PLoS Med 2008; 5:e19.